Search research articles
Contact Us
Filters
Showing results (121-130 of 418) with videos related to
Page
of 42
Sort By:
Journal of Drugs in Dermatology : JDD
|
August 9, 2023
Talquetamab-Induced Grover's Disease
Mindy Kresch, Sophie Guenin, Adnan Mubasher, et al.
Journal of the American Academy of Dermatology
|
June 12, 2025
Reconsidering interferon gamma release assay thresholds and annual retesting in patients receiving biologic therapy for psoriasis
Annika Liu, Austin Maddy, Sylvia Hsu, et al.
International Journal of Dermatology
|
January 18, 2003
Reactive angioendotheliomatosis and sarcoidosis
Eileen Q Shyong, Peter Gorevic, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
March 17, 2017
Regression Analysis of Local Skin Reactions to Predict Clearance of Actinic Keratosis on the Face in Patients Treated With Ingenol Mebutate Gel: Experience from Randomized Controlled Trials
Shelbi Jim On, Kim Mark Knudsen, Torsten Skov, et al.
The Journal of Investigative Dermatology
|
August 20, 2003
Topical calcitriol is degraded by ultraviolet light
Mark Lebwohl, John Quijije, Jean Gilliard, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
May 10, 2006
Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects
Clark C Otley, Thomas Stasko, Whitney D Tope, et al.
Journal of Drugs in Dermatology : JDD
|
October 6, 2023
Successful Treatment of Lichen Planus With Oral Upadacitinib
Melissa P Zundell, Joshua Kaminetsky, Mark Lebwohl, et al.
JAAD Case Reports
|
March 22, 2021
"COVID arm": A reaction to the Moderna vaccine
Nancy Wei, Mary Fishman, Debra Wattenberg, et al.
Cutis
|
August 1, 2008
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses
Annemarie Uliasz, Joshua Zeichner, Jennifer Soung, et al.
Journal of the American Academy of Dermatology
|
June 21, 2005
An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis
Carin H Gribetz, Robin Blum, Christopher Brady, et al.
Page
of 42
Search research articles
Search
Showing results (121-130 of 418) with videos related to
Sort By:
Page
of 42
Journal of Drugs in Dermatology : JDD
|
August 9, 2023
Talquetamab-Induced Grover's Disease
Mindy Kresch, Sophie Guenin, Adnan Mubasher, et al.
Journal of the American Academy of Dermatology
|
June 12, 2025
Reconsidering interferon gamma release assay thresholds and annual retesting in patients receiving biologic therapy for psoriasis
Annika Liu, Austin Maddy, Sylvia Hsu, et al.
International Journal of Dermatology
|
January 18, 2003
Reactive angioendotheliomatosis and sarcoidosis
Eileen Q Shyong, Peter Gorevic, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
March 17, 2017
Regression Analysis of Local Skin Reactions to Predict Clearance of Actinic Keratosis on the Face in Patients Treated With Ingenol Mebutate Gel: Experience from Randomized Controlled Trials
Shelbi Jim On, Kim Mark Knudsen, Torsten Skov, et al.
The Journal of Investigative Dermatology
|
August 20, 2003
Topical calcitriol is degraded by ultraviolet light
Mark Lebwohl, John Quijije, Jean Gilliard, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
May 10, 2006
Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects
Clark C Otley, Thomas Stasko, Whitney D Tope, et al.
Journal of Drugs in Dermatology : JDD
|
October 6, 2023
Successful Treatment of Lichen Planus With Oral Upadacitinib
Melissa P Zundell, Joshua Kaminetsky, Mark Lebwohl, et al.
JAAD Case Reports
|
March 22, 2021
"COVID arm": A reaction to the Moderna vaccine
Nancy Wei, Mary Fishman, Debra Wattenberg, et al.
Cutis
|
August 1, 2008
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses
Annemarie Uliasz, Joshua Zeichner, Jennifer Soung, et al.
Journal of the American Academy of Dermatology
|
June 21, 2005
An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis
Carin H Gribetz, Robin Blum, Christopher Brady, et al.
Page
of 42